Conquering Diseases

Study Of An Experimental Combination Of Drugs For Late Stage Or Recurring Endometrial Cancer

Description

Women with stage III, IVA or IVB or recurrent endometrial cancer for a study adding an additional immunotherapy drug to the usual treatment lowers the chance of the cancer growing or spreading.

Overview

We are studying whether adding an immunotherapy drug to the usual treatment for endometrial cancer reduces the chance of the cancer growing or spreading. Some participants will be randomly assigned to receive the experimental immunotherapy drug and others will receive a placebo (looks like the study drug but contains no medication).

What we're hoping for

We hope that the experimental drug combination will lower the chance of endometrial cancer growing or spreading.

Additional Information

ClinicalTrials.gov Identifier: NCT03914612

 Principal Investigator

Susan  Zweizig, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989